Robert Eferl,
Institute of Cancer Research,
MedUni Vienna

Title: CDHR5 in intestinal tissue homeostasis and cancer

https://krebsforschung.meduniwien.ac.at/forschung-research/research-focuses/cellular-and-molecular-tumor-biology/robert-eferl/

Robert Eferl works in two main topics:
1) identification of cooperative signaling pathways in cancer formation using novel mouse models.
2) functions of STAT transcription factors in inflammatory liver damage and cancer types that are associated with inflammation

Natascha Kleiter,
Section of Translational Cell Genetics,
Medical University Innsbruck

Title: The nuclear orphan receptor NR2F6 as a new cancer immune checkpoint

Natascha Kleiter has characterized NR2F6 as an intracellular immune checkpoint, directly repressing transcription of cytokine genes in T cells relevant for cancer cell rejection and therefore enhancing tumor immune surveillance.

https://phd-school.i-med.ac.at/phd-programs/doctoralprogram/molecular-cell-biology

Christian Stockmann,
Universität Zürich,
Medizinische Fakultät,
Anatomisches Institut

Title: Immune cell-driven angiogenesis affecting organ remodelling during tissue hypoxia

Christian Stockmann’s research group aims to decipher how immune cell-driven angiogenesis affects organ remodeling during tissue hypoxia and also on the role of hypoxia-inducible factors in distinct immune cell subsets and their impact on tissue fibrosis after injury as well as on the progression of malignant tumors.

http://www.anatomy.uzh.ch/en/research/stockmann.html